Demographic and Experiential Correlates of Public Attitudes Towards Cell-Free Fetal DNA Screening

Journal of Genetic Counseling

Volumn 23, Issue 6, 2014, Pages 957-967

  Sayres, Lauren C ^a   Allyse, Megan ^b   Goodspeed, Taylor A ^c   Cho, Mildred K ^c,d  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

Cell free fetal DNA; Non invasive prenatal screening; Non invasive prenatal testing; Prenatal genetic counseling; Public attitudes

Indexed keywords

DNA; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ATTITUDE TO HEALTH; BLOOD; FEMALE; FIRST TRIMESTER PREGNANCY; GENETIC SCREENING; HUMAN; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES; STATISTICAL MODEL; TRISOMY; UNITED STATES;

ATTITUDE TO HEALTH; DNA; FEMALE; GENETIC TESTING; HUMANS; LOGISTIC MODELS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; TRISOMY; UNITED STATES;

EID: 84911990814     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-014-9704-9     Document Type: Article

References (45)

1. Allyse, M, Sayres, LC, Goodspeed, TA, & Cho, MK. (2013). Attitudes towards non-invasive prenatal testing for aneuploidy among United States adults of reproductive age. Journal of Perinatology. doi:10.1038/jp.2014.30.
2. Benn, P. A., & Chapman, A. R. (2009). Practical and ethical considerations of noninvasive prenatal diagnosis. JAMA, 301(20), 2154–2156. doi:10.1001/jama.2009.707.
3. Benn, P. A., & Chapman, A. R. (2010). Ethical challenges in providing noninvasive prenatal diagnosis. Current Opinion in Obstetrics & Gynecology, 22(2), 128–134. doi:10.1097/GCO.0b013e3283372352.
4. Benn, P., Borrell, A., Cuckle, H., Dugoff, L., Gross, S., Johnson, J., et al. (2011). Prenatal detection of Down syndrome using massively parallel sequencing (MPS): A rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis. from http://www.ispdhome.org/public/news/2011/ISPD_RapidResponse_MPS_24Oct11.pdf
5. Bianchi, D. W., Sehnert, A. J., & Rava, R. P. (2012). Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstetrics and Gynecology, 119(6), 1270–1271. doi:10.1097/AOG.0b013e318258c419.
6. Case, A. P., Ramadhani, T. A., Canfield, M. A., & Wicklund, C. A. (2007). Awareness and attitudes regarding prenatal testing among Texas women of childbearing age. Journal of Genetic Counseling, 16(5), 655–661. doi:10.1007/s10897-007-9103-6.
7. Chetty, S., Garabedian, M. J., & Norton, M. E. (2013). Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening. Prenatal Diagnosis, 33(6), 542–546. doi:10.1002/pd.4125.
8. Choi, H., Van Riper, M., & Thoyre, S. (2012). Decision making following a prenatal diagnosis of Down syndrome: an integrative review. Journal of Midwifery & Women’s Health, 57(2), 156–164. doi:10.1111/j.1542-2011.2011.00109.x.
9. Committee opinion number 545: Noninvasive prenatal testing for fetal aneuploidy. (2012). Obstetrics and gynecology, 120(6), 1532–1534. doi: 10.1097/01.AOG.0000423819.85283.f4
10. Devers, P. L., Cronister, A., Ormond, K. E., Facio, F., Brasington, C. K., & Flodman, P. (2012). Noninvasive prenatal testing/noninvasive prenatal diagnosis: The position of the National Society of Genetic Counselors. from http://www.nsgc.org/Portals/0/Advocacy/NSGC%20Noninvasive%20Prenatal%20Testing%204-17-2012.pdf.
11. Dormandy, E., Michie, S., Hooper, R., & Marteau, T. M. (2005). Low uptake of prenatal screening for Down syndrome in minority ethnic groups and socially deprived groups: a reflection of women’s attitudes or a failure to facilitate informed choices? International Journal of Epidemiology, 34(2), 346–352. doi:10.1093/ije/dyi021.
12. Drugan, A., Greb, A., Johnson, M. P., Krivchenia, E. L., Uhlmann, W. R., Moghissi, K. S., et al. (1990). Determinants of parental decisions to abort for chromosome abnormalities. Prenatal Diagnosis, 10(8), 483–490.
13. Garcia, E., Timmermans, D. R., & van Leeuwen, E. (2008a). The impact of ethical beliefs on decisions about prenatal screening tests: searching for justification. Social Science and Medicine, 66(3), 753–764. doi:10.1016/j.socscimed.2007.10.010.
14. Garcia, E., Timmermans, D. R., & van Leeuwen, E. (2008b). Rethinking autonomy in the context of prenatal screening decision-making. Prenatal Diagnosis, 28(2), 115–120. doi:10.1002/pd.1920.
15. Greely, H. T. (2011). Get ready for the flood of fetal gene screening. Nature, 469(7330), 289–291. doi:10.1038/469289a.
16. Heger, M. (2012). Sequenom sees steady growth of MaterniT21 test despite competition, GenomeWeb. Retrieved from http://www.genomeweb.com/sequencing/sequenom-sees-steady-growth-maternit21-test-despite-competition.
17. Heger, M. (2013). Facing increased competition, sequenom sees continued growth of MaterniT21 test in Q4 2012, GenomeWeb. Retrieved from http://www.genomeweb.com/sequencing/facing-increased-competition-sequenom-sees-continued-growth-maternit21-test-q4-2.
18. Kaback, M. M. (2000). Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model. European Journal of Pediatrics, 159(Suppl 3), S192–S195.
19. Kelly, S. E., & Farrimond, H. R. (2012). Non-invasive prenatal genetic testing: a study of public attitudes. Public Health Genomics, 15(2), 73–81. doi:10.1159/000331254.
20. Kent, A. (2008). Non-invasive prenatal diagnosis: public and patient perceptions. Seminars in Fetal & Neonatal Medicine, 13(2), 109–112. doi:10.1016/j.siny.2007.12.009.
21. Kitzman, J. O., Snyder, M. W., Ventura, M., Lewis, A. P., Qiu, R., Simmons, L. E., et al. (2012). Noninvasive whole-genome sequencing of a human fetus. Science Translational Medicine, 4(137), 137–176. doi:10.1126/scitranslmed.3004323.
22. Kooij, L., Tymstra, T., & Berg, P. (2009). The attitude of women toward current and future possibilities of diagnostic testing in maternal blood using fetal DNA. Prenatal Diagnosis, 29(2), 164–168. doi:10.1002/pd.2205.
23. Kramer, R. L., Jarve, R. K., Yaron, Y., Johnson, M. P., Lampinen, J., Kasperski, S. B., et al. (1998). Determinants of parental decisions after the prenatal diagnosis of Down syndrome. American Journal of Medical Genetics, 79(3), 172–174.
24. Kuppermann, M., Gates, E., & Washington, A. E. (1996). Racial-ethnic differences in prenatal diagnostic test use and outcomes: preferences, socioeconomics, or patient knowledge? Obstetrics and Gynecology, 87(5 Pt 1), 675–682.
25. Kuppermann, M., Nakagawa, S., Cohen, S. R., Dominguez-Pareto, I., Shaffer, B. L., & Holloway, S. D. (2011). Attitudes toward prenatal testing and pregnancy termination among a diverse population of parents of children with intellectual disabilities. Prenatal Diagnosis, 31(13), 1251–1258. doi:10.1002/pd.2880.
26. Lewis, C., Hill, M., Skirton, H., & Chitty, L. S. (2012). Fetal sex determination using cell-free fetal DNA: service users’ experiences of and preferences for service delivery. Prenatal diagnosis, 1–7. doi: 10.1002/pd.3893
27. Lewis, C., Silcock, C., & Chitty, L. S. (2013). Non-invasive prenatal testing for Down’s syndrome: pregnant women’s views and likely uptake. Public Health Genomics, 16(5), 223–232. doi:10.1159/000353523.
28. Lo, Y. M., & Chiu, R. W. (2012). Genomic analysis of fetal nucleic acids in maternal blood. Annual Review of Genomics and Human Genetics, 13, 285–306. doi:10.1146/annurev-genom-090711-163806.
29. Malone, F. D., Canick, J. A., Ball, R. H., Nyberg, D. A., Comstock, C. H., & Bukowski, R. (2005). First-trimester or second-trimester screening, or both, for Down’s syndrome. New England Journal of Medicine, 353(19), 2001–2011. doi:10.1056/NEJMoa043693.
30. Markens, S., Browner, C. H., & Press, N. (1999). ‘Because of the risks’: how US pregnant women account for refusing prenatal screening. Social Science & Medicine, 49(3), 359–369.
31. Natoli, J. L., Ackerman, D. L., McDermott, S., & Edwards, J. G. (2012). Prenatal diagnosis of Down syndrome: a systematic review of termination rates (1995–2011). Prenatal Diagnosis, 32(2), 142–153. doi:10.1002/pd.2910.
32. Olney, R. S., Moore, C. A., Khoury, M. J., Erickson, J. D., Edmonds, L. D., Botto, L. D., et al. (1995). Chorionic villus sampling and amniocentesis: recommendations for prenatal counseling. Morbidity and Mortality Weekly Report. Recommendations and Reports, 44(RR-9), 1–12.
33. Palomaki, G. E., Knight, G. J., McCarthy, J. E., Haddow, J. E., & Donhowe, J. M. (1997). Maternal serum screening for Down syndrome in the United States: a 1995 survey. American Journal of Obstetrics and Gynecology, 176(5), 1046–1051.
34. Parens, E., & Asch, A. (2000). Prenatal testing and disability rights. Washington, D.C.: Georgetown University Press.
35. Peters, D., Chu, T., Yatsenko, S. A., Hendrix, N., Hogge, W. A., Surti, U., et al. (2011). Noninvasive prenatal diagnosis of a fetal microdeletion syndrome. The New England Journal of Medicine, 365(19), 1847–1848. doi:10.1056/NEJMc1106975.
36. Poon, C., Ng, W., Kou, K., Lau, B., Ma, T., & Leung, K. (2013). Impact of introduction of non-invasive prenatal testing in private on the uptake of prenatal testing for Down syndrome in a public hospital. Ultrasound in Obstetrics & Gynecology, 42(s1), 130.
37. Press, N., & Browner, C. H. (1997). Why women say yes to prenatal diagnosis. Social Science & Medicine, 45(7), 979–989.
38. Rapp, R. (1998). Refusing prenatal diagnosis: the meanings of bioscience in a multicultural world. Science, Technology & Human Values, 23(1), 45–70.
39. Rasmussen, S. A., Wong, L. Y., Yang, Q., May, K. M., & Friedman, J. M. (2003). Population-based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics, 111(4 Pt 1), 777–784.
40. Sayres, L. C., Allyse, M., Norton, M. E., & Cho, M. K. (2011). Cell-free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementation. Prenatal Diagnosis. doi:10.1002/pd.2835.
41. Suter, S. M. (2002). The routinization of prenatal testing. American Journal of Law and Medicine, 28(2–3), 233–270.
42. Tischler, R., Hudgins, L., Blumenfeld, Y. J., Greely, H. T., & Ormond, K. E. (2011). Noninvasive prenatal diagnosis: pregnant women’s interest and expected uptake. Prenatal Diagnosis, 31(13), 1292–1299. doi:10.1002/pd.2888.
43. Yi, H., Hallowell, N., Griffiths, S., & Yeung Leung, T. (2013). Motivations for undertaking DNA sequencing-based non-invasive prenatal testing for fetal aneuploidy: a qualitative study with early adopter patients in Hong Kong. PLoS One, 8(11), e81794. doi:10.1371/journal.pone.0081794.
44. Yotsumoto, J., Sekizawa, A., Koide, K., Purwosunu, Y., Ichizuka, K., Matsuoka, R., et al. (2012). Attitudes toward non-invasive prenatal diagnosis among pregnant women and health professionals in Japan. Prenatal diagnosis, 1–6. doi: 10.1002/pd.3886.
45. Zamerowski, S. T., Lumley, M. A., Arreola, R. A., Dukes, K., & Sullivan, L. (2001). Favorable attitudes toward testing for chromosomal abnormalities via analysis of fetal cells in maternal blood. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 3(4), 301–309.